(XERS) Xeris Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xeris Pharmaceuticals | (XERS) share price targets
Complete technical analysis of Xeris Pharmaceuticals (XERS) by charts plus indicators, forecast predictions and share price targets for Xeris Pharmaceuticals (XERS)
Xeris Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-10 View latest technical analysis
10 day averaged volume of Xeris Pharmaceuticals is 1134758
Date | Daily Closing Price | Open | High | Low | Volume |
10 Tue Dec 2024 | 3.58 | 3.61 | 3.74 | 3.57 | 1.312 times |
09 Mon Dec 2024 | 3.61 | 3.69 | 3.75 | 3.60 | 0.603 times |
26 Tue Nov 2024 | 3.18 | 3.08 | 3.20 | 3.07 | 1.165 times |
26 Tue Nov 2024 | 3.18 | 3.08 | 3.20 | 3.07 | 1.165 times |
25 Mon Nov 2024 | 3.08 | 3.09 | 3.14 | 3.05 | 0.704 times |
22 Fri Nov 2024 | 3.09 | 3.04 | 3.10 | 3.02 | 0.648 times |
21 Thu Nov 2024 | 3.04 | 3.08 | 3.12 | 3.03 | 1.143 times |
20 Wed Nov 2024 | 3.06 | 2.99 | 3.08 | 2.96 | 0.938 times |
19 Tue Nov 2024 | 3.01 | 2.86 | 3.01 | 2.86 | 0.691 times |
18 Mon Nov 2024 | 2.90 | 2.91 | 2.93 | 2.82 | 1.247 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 3.6, for a target of 3.4 or 3.2
Share price targets for Xeris Pharmaceuticals (XERS)
Target Type | Value |
Downside Target | 2.10 |
Downside Target | 2.48 |
Downside Target | 2.69 |
Downside Target | 2.82 |
Downside Target | 2.91 |
Downside Target | 3.04 |
Downside Target | 3.20 |
Downside Target | 3.39 |
Downside Target | 3.43 |
Downside Target | 3.57 |
Upside Target | 3.64 |
Upside Target | 3.75 |
Intraday share price targets for Xeris Pharmaceuticals (XERS)
Target Type | Value |
Downside Intraday Target | 3.52 |
Downside Intraday Target | 3.45 |
Upside Intraday Target | 3.7 |
Upside Intraday Target | 3.81 |
Upside Intraday Target | 3.63 |
Weekly technical analysis of Xeris Pharmaceuticals (XERS)
Date | Weekly Closing Price | Open | High | Low | Volume |
10 Tue Dec 2024 | 3.58 | 3.69 | 3.75 | 3.57 | 1.644 times |
26 Tue Nov 2024 | 3.18 | 3.08 | 3.20 | 3.07 | 0.623 times |
26 Tue Nov 2024 | 3.18 | 3.09 | 3.20 | 3.05 | 0.4 times |
22 Fri Nov 2024 | 3.09 | 2.91 | 3.12 | 2.82 | 0.443 times |
15 Fri Nov 2024 | 2.92 | 3.43 | 3.43 | 2.91 | 0.837 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Xeris Pharmaceuticals (XERS)
Date | Monthly Closing Price | Open | High | Low | Volume |
10 Tue Dec 2024 | 3.58 | 3.69 | 3.75 | 3.57 | 0.061 times |
26 Tue Nov 2024 | 3.18 | 3.26 | 3.64 | 2.82 | 1.286 times |
31 Thu Oct 2024 | 3.22 | 2.85 | 3.39 | 2.69 | 0.76 times |
30 Mon Sep 2024 | 2.85 | 2.79 | 3.04 | 2.48 | 1.008 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xeris Pharmaceuticals (XERS)
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xeris Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Xeris Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Xeris Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.17 and Xeris Pharmaceuticals (XERS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xeris Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Xeris Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Xeris Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.17 and Xeris Pharmaceuticals (XERS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.